Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123555656 | 12355565 | 6 | F | 20141003 | 20160926 | 20160511 | 20160930 | EXP | CA-JNJFOC-20160323328 | JANSSEN | 17.05 | YR | T | M | Y | 82.00000 | KG | 20160930 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123555656 | 12355565 | 1 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | U | FLM04014;ELM02016;ELM02015 | 0 | LYOPHILIZED POWDER | |||||||
| 123555656 | 12355565 | 2 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | U | FLM04014;ELM02016;ELM02015 | 0 | 10 | MG/KG | LYOPHILIZED POWDER | |||||
| 123555656 | 12355565 | 3 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | U | FLM04014;ELM02016;ELM02015 | 0 | 10 | MG/KG | LYOPHILIZED POWDER | |||||
| 123555656 | 12355565 | 4 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | U | FLM04014;ELM02016;ELM02015 | 0 | 10 | MG/KG | LYOPHILIZED POWDER | |||||
| 123555656 | 12355565 | 5 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | U | FLM04014;ELM02016;ELM02015 | 0 | 400 | MG | LYOPHILIZED POWDER | |||||
| 123555656 | 12355565 | 6 | PS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | U | FLM04014;ELM02016;ELM02015 | 103772 | 400 | MG | LYOPHILIZED POWDER | |||||
| 123555656 | 12355565 | 7 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | D | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123555656 | 12355565 | 1 | Crohn's disease |
| 123555656 | 12355565 | 2 | Crohn's disease |
| 123555656 | 12355565 | 3 | Crohn's disease |
| 123555656 | 12355565 | 4 | Crohn's disease |
| 123555656 | 12355565 | 5 | Crohn's disease |
| 123555656 | 12355565 | 6 | Crohn's disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123555656 | 12355565 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123555656 | 12355565 | Abdominal pain | |
| 123555656 | 12355565 | Drug ineffective | |
| 123555656 | 12355565 | Frequent bowel movements | |
| 123555656 | 12355565 | General physical health deterioration | |
| 123555656 | 12355565 | Off label use | |
| 123555656 | 12355565 | Product use issue | |
| 123555656 | 12355565 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123555656 | 12355565 | 1 | 20140612 | 0 | ||
| 123555656 | 12355565 | 3 | 20160602 | 0 | ||
| 123555656 | 12355565 | 4 | 20141003 | 0 | ||
| 123555656 | 12355565 | 5 | 20141009 | 0 | ||
| 123555656 | 12355565 | 6 | 20160505 | 0 |